HPV (human papillomavirus) is a known precursor to cervical cancer. This is why so much effort has been put into possibly finding a vaccine that would prevent women from contracting HPV. Recently Merck released some findings from a study indicating that a vaccine they have been working on had great results in preventing women from contracting HPV.
Why are we talking about this here you might ask? Well, cervical cancer can be misdiagnosed and that leads to malpractice cases. Generally the case is against the person who did not read the pathology slides correctly.
So, a vaccine that might prevent large numbers of women from ever having this disease is huge. It’s a benefit across the board. Here’s what USA Today and Forbes had to say about this vaccine.
Posted by Dave Austin 
Click here to Subscribe to RSS Feed
